Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
International Journal of Molecular Sciences
|
October 14, 2022
MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment
André T S Vicente, Jorge A R Salvador
Expert Opinion on Therapeutic Patents
|
April 26, 2021
A patent review of glutaminyl cyclase inhibitors (2004-present)
Judite R M Coimbra, Jorge A R Salvador
Medcomm
|
June 7, 2024
PROteolysis-Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
André T S Vicente, Jorge A R Salvador
Expert Opinion on Therapeutic Patents
|
July 26, 2023
Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the treatment of chronic myeloid leukemia - a patent review
André T S Vicente, Jorge A R Salvador
Frontiers in Chemistry
|
October 3, 2022
Highlights in USP7 inhibitors for cancer treatment
Rita I Oliveira, Romina A Guedes, Jorge A R Salvador
International Journal of Molecular Sciences
|
February 10, 2024
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?
Ângela Gonçalves, Mariana Matias, Jorge A R Salvador, et al.
Bioorganic & Medicinal Chemistry
|
September 11, 2012
Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells
Ana S Leal, Rui Wang, Jorge A R Salvador, et al.
Molecules (Basel, Switzerland)
|
April 6, 2011
Bismuth(III) reagents in steroid and terpene chemistry
Jorge A R Salvador, Samuel M Silvestre, Rui M A Pinto
Chemmedchem
|
July 19, 2012
Semisynthetic ursolic acid fluorolactone derivatives inhibit growth with induction of p21(waf1) and induce apoptosis with upregulation of NOXA and downregulation of c-FLIP in cancer cells
Ana S Leal, Rui Wang, Jorge A R Salvador, et al.
Acta Crystallographica. Section C, Crystal Structure Communications
|
May 3, 2008
5Beta,6beta-epoxy-17-oxoandrostan-3beta-yl acetate and 5beta,6beta-epoxy-20-oxopregnan-3beta-yl acetate
Rui M A Pinto, Jorge A R Salvador, José A Paixão
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
International Journal of Molecular Sciences
|
October 14, 2022
MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment
André T S Vicente, Jorge A R Salvador
Expert Opinion on Therapeutic Patents
|
April 26, 2021
A patent review of glutaminyl cyclase inhibitors (2004-present)
Judite R M Coimbra, Jorge A R Salvador
Medcomm
|
June 7, 2024
PROteolysis-Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
André T S Vicente, Jorge A R Salvador
Expert Opinion on Therapeutic Patents
|
July 26, 2023
Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the treatment of chronic myeloid leukemia - a patent review
André T S Vicente, Jorge A R Salvador
Frontiers in Chemistry
|
October 3, 2022
Highlights in USP7 inhibitors for cancer treatment
Rita I Oliveira, Romina A Guedes, Jorge A R Salvador
International Journal of Molecular Sciences
|
February 10, 2024
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?
Ângela Gonçalves, Mariana Matias, Jorge A R Salvador, et al.
Bioorganic & Medicinal Chemistry
|
September 11, 2012
Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells
Ana S Leal, Rui Wang, Jorge A R Salvador, et al.
Molecules (Basel, Switzerland)
|
April 6, 2011
Bismuth(III) reagents in steroid and terpene chemistry
Jorge A R Salvador, Samuel M Silvestre, Rui M A Pinto
Chemmedchem
|
July 19, 2012
Semisynthetic ursolic acid fluorolactone derivatives inhibit growth with induction of p21(waf1) and induce apoptosis with upregulation of NOXA and downregulation of c-FLIP in cancer cells
Ana S Leal, Rui Wang, Jorge A R Salvador, et al.
Acta Crystallographica. Section C, Crystal Structure Communications
|
May 3, 2008
5Beta,6beta-epoxy-17-oxoandrostan-3beta-yl acetate and 5beta,6beta-epoxy-20-oxopregnan-3beta-yl acetate
Rui M A Pinto, Jorge A R Salvador, José A Paixão
Page
of 7